Vimentin-positive adenocarcinomas of the stomach: Co-expression of vimentin and cytokeratin

Histopathology

Volumn 29, Issue 6, 1996, Pages 507-516

  Utsunomiya, T ^a   Yao, T ^a   Masuda, K ^a   Tsuneyoshi, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

adenocarcinoma; cytokeratin; stomach; vimentin

Indexed keywords

CYTOKERATIN; VIMENTIN;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA;

EID: 0030459110     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-538.x     Document Type: Article

References (38)

1. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31; 11-24.
2. Gatter KC, Abdulaziz Z, Beverley P et al. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J. Clin. Pathol. 1982; 35; 1253-1267.
3. Osborn M, Weber K. Tumor diagnosis by intermediate filament typing: a novel tool, for surgical pathology. Lab. Invest. 1983; 48; 372-394.
4. Beham A, Ratschek M, Zatloukal K, Schmid C, Denk H. Distribution of cytokeratins, vimentin and desmoplakins in normal renal tissue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy. Virchows Archiv. A Pathol. Anat. 1992; 421; 209-213.
5. Holck S, Pedersen L, Schiodt T, Zedeler K, Mouridsen H. Vimentin expression in 98 breast cancers with medullary features and its prognostic significance. Virchows Archiv. A Pathol. Anat. 1993; 422; 475-479.
6. Domagala W, Lasata J, Bartkowiak J, Weber K, Osborn M. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am. J. Pathol. 1990; 136; 219-227.
7. Raymond WA, Leong AS. Vimentin-a new prognostic parameter in breast carcinoma? J. Pathol. 1989; 158; 107-114.
8. Upton MP, Hirohashi S, Tome Y et al. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am. J. Surg. Pathol. 1986; 10; 560-567.
9. Miettinen M, Franssila K, Lehto V, Paasivuo R, Vietanen I. Expression of intermediate filament proteins in thyroid gland and thyroid tumors. Lab. Invest. 1984; 50; 262-270.
10. Dabbs DJ, Geisinger KR, Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. Am. J. Surg. Pathol. 1986; 10; 568-576.
11. Jones EA, Flejou JF, Molas G, Potet F. Pleomorphic carcinoma of the small bowel. Path. Res. Pract. 1991; 187; 235-240.
12. Bak M, Teglbjærg PS. Pleomorphic (giant cell) carcinoma of the intestine. Cancer 1989; 64; 2557-2564.
13. Ueyama T, Nagai E, Yao T, Tsuneyoshi M. Vimentin-positive gastric carcinomas with rhabdoid features. Am. J. Surg. Pathol. 1993; 17; 813-819.
14. Robey-Cafferty SS, Grignon DJ, Ro JY et al. Sarcomatoid carcinoma of the stomach. Cancer 1990; 65; 1601-1606.
15. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. Am. J. Pathol. 1992; 140; 427-447.
16. Kaibara N, Kimura O, Nishidoi H et al. High incidence of liver metastasis in gastric cancer with medullary growth pattern. J. Surg. Oncol 1985; 28; 195-198.
17. Adachi Y, Mori M, Maehara Y, Sugimachi K. Pooly differentiated medullary carcinoma of the stomach. Cancer 1992; 70; 1462-1466.
18. Hirato J, Nakazato Y, Ogawa A. Expression of non-glial intermediate filament proteins in gliomas. Clin. Neuropathol. 1991;13; 1-11.
19. Knapp AC, Franke WW. Spontaneous losses of control, of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell 1989; 59; 67-79.
20. Arber DA, Kandalaft PL, Mehta P, Battifora U. Vimentin-negative epithelioid sarcoma. Am. J. Surg. Pathol. 1993; 17; 302-307.
21. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. First English edn. The general rules for the gastric cancer study in surgery. Am. J. Surg. 1995; 1; 1-65.
22. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta. Pathol. Microbiol. Scand. 1965; 64; 47-50.
23. Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Cancer 1994; 73; 2239-2249.
24. Shi S, Key ME, Kalra L. Antigen retrieval in formalin-fixed, paraffin-embedded tissue: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 1991; 39; 741-748.
25. Osamura Y, Watanabe K, Nakai Y, Imura H. Adrenocorticotropic hormone cells and immunoreactive β-endorphic cells in the human pituitary gland. Am. J. Pathol. 1980; 99; 105-124.
26. Bonifas JM, Rothman AL, Epstein EH. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 1991; 254; 1202-1205.
27. Coulombe PA, Hutton ME, Vassar R, Fuchs E. A function for keratin and a common thread among different types of epidermolysis bullosa simplex diseases. J. Cell. Biol. 1991; 115; 1661-1674.
28. Lane EB, Rugg EL, Navsaria H et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992; 356; 244-246.
29. Franke WW, Schmid E, Winter S, Osborn M, Weber K. Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates. Exp. Cell. Res. 1979; 123; 25-46.
30. Virtanen I, Lehto VP, Lehtonen E, Vartio T, Stenman S. Expression of intermediate filaments in cultured cells. J. Cell. Sci. 1981; 50; 45-63.
31. Raz A, Ben-Ze'ev A. Modulation of the metastatic capability in B16 melanoma by cell shape. Science 1983; 23; 1307-1310.
32. Ben-Ze'ev A. Cell density and cell shape-related regulation of vimentin and cytokeratin synthesis. Exp. Cell. Res. 1985; 1985; 520-532.
33. Kinjo M, Winter H, Schweizer J. Differential expression of intermediate filament proteins in two rat ascites hepatoma lines of common origin. Carcinogenesis 1984; 5; 1249-1255.
34. Gorodeski GI, Romero MF, Hopfer U et al. Human uterine cervical epithelial cells grown on permeable support,-a new model for the study of differentiation. Differentiation 1994; 56; 107-118.
35. Uchida H, Nakayama I, Noguchi S. An immunohistochemical study of cytokeratin and vimentin in benign and malignant thyroid lesions. Acta. Pathol. Jpn. 1989; 39; 169-175.
36. Lane EB, Hogan BLM, Kurkinen M, Garrels. Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature 1983; 303; 701-704.
37. Ben-Ze'ev A, Zöller M, Raz A. Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumor. Cancer Res. 1986; 46; 785-790.
38. Matzku s, Komitowski D, Mildenberger M, Zöller M. Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacity. Invasion Metastasis 1983; 3; 109-123.